1. Osthole shows the potential to overcome P-glycoprotein-mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway
   HONG WANG et al, 2016 CrossRef
2. Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling
   Xiaofan Yang et al, 2017, Chemico-Biological Interactions CrossRef
3. Contribution of nucleophosmin overexpression to multidrug resistance in breast carcinoma
   Siying Chen et al, 2018, Journal of Drug Targeting CrossRef
4. TGF-β1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells
   Qian-Zhao Chen et al, 2017 CrossRef
5. LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy
   XIN HUA LONG et al, 2014 CrossRef
6. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway
   Hong Wang et al, 2016 CrossRef
7. Vasoactive intestinal peptide receptor-based imaging and treatment of tumors
   BO TANG et al, 2014 CrossRef
8. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway
   JIE-RU CHEN et al, 2016 CrossRef
9. BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells.
   Rong-Xing Liu et al, 2017, Int J Oncol CrossRef
10. Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer
    SI-YING CHEN et al, 2016 CrossRef
11. miR-196b regulates gastric cancer cell proliferation and invasion via PI3K/AKT/mTOR signaling pathway
    NA LI et al, 2016 CrossRef
12. Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis
    Yaoyong Lu et al, 2017 CrossRef
13. NLS-RARα modulates acute promyelocytic leukemia NB4 cell proliferation and differentiation via the PI3K/AKT pathway
    Hao Song et al, 2016 CrossRef
14. The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
    Tasuku Matsuoka et al, 2014, Cancers CrossRef
15. Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells
    Jessika Bertacchini et al, 2018, Advances in Biological Regulation CrossRef
16. Milk fat globule membrane protein promotes C 2 C 12 cell proliferation through the PI3K/Akt signaling pathway
    He Li et al, 2018, International Journal of Biological Macromolecules CrossRef
17. The Clinical and Biological Significance of Tyrosine Kinases in Gastric Cancer
    Neelam Khetpal et al, 2018 CrossRef
18. Investigating Potential Molecular Mechanisms of Carcinogenesis and Genes as Biomarkers for Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis
    Yi Zhu et al, 2018, Pathol. Oncol. Res. CrossRef
19. Podocalyxin‐like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein
    Qiaoming Zhi et al, 2018, Cancer Sci CrossRef
20. Foxo3a-dependent miR-633 regulates chemotherapeutic sensitivity in gastric cancer by targeting Fas-associated death domain
    Xin Pang et al, 2019, RNA Biology CrossRef
21. Long non-coding RNA GACAT1 alleviates doxorubicin and vincristine resistance through a PTEN/AKT/mTOR/S6K1 regulatory pathway in gastric cancer
    Hengxuan Ding et al, 2019, RSC Adv. CrossRef
22. Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway
    B Tan et al, 2014, Cancer Gene Ther CrossRef
23. Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway
    Meihan Liu et al, 2019, J Cell Physiol CrossRef
24. Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?
    Donal McLornan et al, 2013, J. Cell. Mol. Med. CrossRef
25. Overcoming of P-glycoprotein-mediated multidrug resistance of tumors in vivo by drug combinations
    Mohamed Saeed et al, 2014, Synergy CrossRef
26. 5-Hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone, a polymethoxyflavone, exerts antitumor effect on PI3K/Akt signaling pathway in human gastric cancer cell BGC-7901
    Xinjian Wang et al, 2016, Journal of Receptors and Signal Transduction CrossRef
27. PIK3CA and PIK3CB silencing by RNAi reverse MDR and inhibit tumorigenic properties in human colorectal carcinoma
    Shuhua Wu et al, 2016, Tumor Biol. CrossRef
28. Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946).
    William J Scott et al, 2016, ChemMedChem CrossRef
29. ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
    Norman Fultang et al, 2020, Sci Rep CrossRef
30. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway
    Jie Luo et al, 2020, Exp Physiol CrossRef
31. A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer.
    Tuo Ruan et al, 2020, Onco Targets Ther CrossRef
32. Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr)
    Gayathri Karanam et al, 2020, Mol Biol Rep CrossRef
33. Enhanced chemosensitization of anoikis-resistant melanoma cells through syndecan-2 upregulation upon anchorage independency
    TingTing Tseng et al, 2017, Oncotarget CrossRef
34. PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
    Shengwei Liu et al, 2017, Oncotarget CrossRef
35. The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study
    Letizia Porcelli et al, 2020, Sci Rep CrossRef
36. Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines
    Chung-Pu Wu et al, 2020, Biochemical Pharmacology CrossRef
37. Interference of P-REX2a may inhibit proliferation and reverse the resistance of SGC7901 cells to doxorubicin
    Yaowei Ai et al, 2017, Oncol Lett CrossRef
38. Identification of differentially expressed genes and biological pathways in bladder cancer.
    Fucai Tang et al, 0 CrossRef
39. PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.
    Rui Liu et al, 2020, Cell Death Dis CrossRef
40. Indole Curcumin Reverses Multidrug Resistance by Reducing the Expression of ABCB1 and COX2 in Induced Multidrug Resistant Human Lung Cancer Cells
    Sankar Pajaniradje et al, 2020, LDDD CrossRef
41. The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives.
    Sayeh Mottaghi et al, 2021, Phytother Res CrossRef
42. Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
    Torki A. Zughaibi et al, 2021, IJMS CrossRef
43. Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells
    Qun Zhao et al, 2016, oncol res CrossRef
44. An engineered abcb4 expression model reveals the central role of NF‐κB in the regulation of drug resistance in zebrafish
    Cong‐Jie Sun et al, 2022, Drug Development Research CrossRef
45. Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance
    Kazem Nejati et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
46. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
    Rui Qin et al, 2022, J Hematol Oncol CrossRef
47. Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
    Rong Zhang et al, 2022, Braz. J. Pharm. Sci. CrossRef
48. Novel indole retinoid derivative induces apoptosis and cell cycle arrest and modulates AKT and ERK signaling in HL‐60 cells
    A. Selen Gurkan‐Alp et al, 2023, Fundamemntal Clinical Pharma CrossRef
49. Gastrointestinal cancer resistance to treatment: the role of microbiota
    Leila Kolahi Sadeghi et al, 2024, Infect Agents Cancer CrossRef
50. Carotenoids as modulators of the PI3K/Akt/mTOR pathway: innovative strategies in cancer therapy
    Biswajit Kumar Utpal et al, 2024, Med Oncol CrossRef